Kristina Shen-Gupta
General Partner @ Andreessen Horowitz
San Francisco, United States
Kristina Shen-Gupta is a Series A investor at Andreessen Horowitz in San Francisco focused on Software and SaaS. Kristina Shen is a Manag8ing Partner at Chemistry VC. She previously worked as an Associate in the Menlo Park, CA office and focuses on investments in the cloud-computing and internet sectors. Prior to joining Bessemer, Kristina was an Associate at JMI Equity, a growth equity investment firm based in San Diego, where she focused on sourcing andinvesting in the software sector. Her investment experience includes WhiteHat Security, a SaaS web application security company.Prior to JMI Equity, Kristina worked in technology investment banking at Goldman Sachs and Credit Suisse, where she worked across a broad range of technology sectors and transactions. Her experience includes working on the IPOs of Palo Alto Networks, Zynga, Fusion-io and Infoblox, as well as the sale of Q1 Labs to IBM and Goldman Sachs’ investment in Kno, Inc. Previously, Kristina held internships at Revolution Partners and Fisher Investments.Kristina graduated with a B.A. in Operations Research and Management Science from UC Berkeley.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 73%
Last updated:
For AI agents: llms.txt
Industries Kristina Shen-Gupta invests in
Stages Kristina Shen-Gupta invests in
Countries Kristina Shen-Gupta invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 11 (42%)
- SaaS 5 (19%)
- Information Technology 4 (15%)
- Artificial Intelligence 3 (12%)
- Apps 2 (8%)
Stage
- Series A 10 (38%)
- Series B 3 (12%)
- Series C 3 (12%)
- Seed 2 (8%)
- Series D 2 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $120M / Series C / Jun 24, 2026 | ||
| Nova Intelligence is the leading agentic AI platform for SAP teams. Our AI agents help enterprises document and understand custom code, reduce complexity by leveraging SAP standard whenever possible, and modernize and build new applications—all with Clean Core compliant, upgrade-safe principles. SAP teams using Nova double their productivity. Theteam behind Nova includes the co-inventor of SAP HANA, an AI researcher from Google DeepMind, and the former CIO of Cargill. The company is backed by SAP's investment arm and top Silicon Valley VCs. | $31.5M / Series A / May 05, 2026 | ||
| The AI agent for procurement | $30M / Series A / Feb 12, 2026 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $76M / Series B / Oct 02, 2025 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $22M / Series A / Apr 16, 2025 | ||
| Relay lets you create playbooks for the operational workflows your team relies on, letting you combine human tasks and automated actions in a single playbook. | $3.1M / Seed / Oct 11, 2023 | ||
| Macro is an Information Technology firm that specializes in SAAS solutions. | $9.4M / Seed / Feb 08, 2023 | ||
| Equals is the only spreadsheet with built-in connections to any database, versioning, and collaboration. | $16M / Series A / Nov 09, 2022 | ||
| Sprig is the product development lifecycle research platform with a mission to make experiences that matter. Companies use Sprig’s Concept and Usability Testing and In-Product Surveys to get research insights from users about new ideas, designs, and prototypes, as well as currently available product experiences. Dropbox, Square, Opendoor, and Loomtrust Sprig to help them build better products. | $30M / Series B / Aug 02, 2022 | ||
| Rutter develops a universal API that integrates with every commerce, accounting, and payments platform. It enables users to connect to any platform and get a holistic view of any business. | $27M / Series A / Mar 15, 2022 | ||
| See all 26 investments → | |||
Co-Investors
About Andreessen Horowitz
Andreessen Horowitz supplies capital deployments across multiple development phases, ranging from early-stage seed investments to late-stage growth financing. Its specialized market coverage spans diverse sectors, including artificial intelligence, biological healthcare, consumer technologies, decentralized cryptocurrency networks, financial technology, and enterprise software infrastructure. Beyond capital allocations, the organization delivers operational support services by connecting corporate portfolio entities with a structured ecosystem of technical advisors, executive talent, and industry operators.
Andreessen Horowitz Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Chen
General Partner
|
|||
Anish Acharya
General Partner
|
|||
David George
General Partner
|
|||
Emily Bennett
investing partner
|
|||
Gabriel Vasquez
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Kristina Shen-Gupta invest in?
Kristina Shen-Gupta invests primarily in Software, SaaS and Information Technology startups, most often at Series A and Series B stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kristina Shen-Gupta?
Public channels for Kristina Shen-Gupta include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kristina Shen-Gupta last invest?
The most recent investment recorded for Kristina Shen-Gupta closed in Jun 2026. Shizune tracks 26 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
